tiprankstipranks
Trending News
More News >
Abbisko Cayman Limited (HK:2256)
:2256
Hong Kong Market

Compare Abbisko Cayman Limited (2256) vs. Competitors

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Abbisko Cayman Limited
HK$13.02
HK$9.79B
51.45
223.60%
5 Buy
0 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$9.58
HK$10.65B
41.67
223.37%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$12.33
HK$12.49B
-44.18
311.44%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$12.36B
18.94
478.51%
CStone Pharmaceuticals
HK$5.34
HK$8.41B
-18.58
163.18%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$9.48
HK$5.90B
153.40
12.59%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2256
Abbisko Cayman Limited
14.40
10.05
231.03%
HK:9966
Alphamab Oncology
10.93
7.70
238.39%
HK:1672
Ascletis Pharma, Inc.
12.59
9.41
295.91%
HK:2142
HBM Holdings Ltd.
14.00
11.33
424.34%
HK:2616
CStone Pharmaceuticals
5.79
3.70
177.03%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.48
0.79
9.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts